Palivizumab | Annual Sales Report

BePharma

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Abbvie

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2017 Revenue in Millions : 738

2016 Revenue in Millions : 730

Growth (%) : 1

Portfolio PDF

Product Web Link

Corporate PDF

02 Brand Name : Synagis

BePharma

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Abbvie

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2016 Revenue in Millions : 730

2015 Revenue in Millions : 740

Growth (%) : -1

Portfolio PDF

Product Web Link

Corporate PDF

03 Brand Name : Synagis

BePharma

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AbbVie

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2015 Revenue in Millions : 835

2014 Revenue in Millions : 740

Growth (%) : -11%

Portfolio PDF

Product Web Link

Corporate PDF

04 Brand Name : Synagis

BePharma

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Abbvie

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2018 Revenue in Millions : 726

2017 Revenue in Millions : 738

Growth (%) : -2%

Portfolio PDF

Product Web Link

Corporate PDF

05 Brand Name : Synagis

BePharma

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AbbVie

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2019 Revenue in Millions : 718

2018 Revenue in Millions : 726

Growth (%) : -1

Portfolio PDF

Product Web Link

Corporate PDF

06 Brand Name : Synagis

BePharma

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AbbVie

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2014 Revenue in Millions : 1.00%

2013 Revenue in Millions :

Growth (%) :

Portfolio PDF

Product Web Link

Corporate PDF

07 Brand Name : Synagis

BePharma

Not Confirmed

08 Brand Name : Synagis

BePharma

Not Confirmed

09 Brand Name : Synagis

BePharma

Not Confirmed

10 Brand Name : Synagis